We aimed to summarize the current situation of SLN mapping in gynecologic cancers. (J Turk Ger Gynecol Assoc 2021; 22: 242-8)
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Lymph node metastasis both increases disease stage and alters adjuvant treatment plans in gynecologic cancers.
📊
Key Findings & Data:Although it is yet an experimental approach in ovarian cancer, it has been incorporated into guidelines for endometrial, cervical and vulvar cancers.
💡
Conclusion & Impact:We aimed to summarize the current situation of SLN mapping in gynecologic cancers. (J Turk Ger Gynecol Assoc 2021; 22: 242-8)
🔬Design:Research Article
📍Scope:2021 Verileri
⚙️Variables:Domain Parameters
Abstract
Lymph node metastasis both increases disease stage and alters adjuvant treatment plans in gynecologic cancers. Since a minority of the patients have nodal metastasis, many patients unnecessarily undergo complete lymphadenectomy and are exposed to the subsequent morbidities. Sentinel lymph node (SLN) mapping is an alternative for evaluation of lymph nodes with lesser side effects. Although it is yet an experimental approach in ovarian cancer, it has been incorporated into guidelines for endometrial, cervical and vulvar cancers. We aimed to summarize the current situation of SLN mapping in gynecologic cancers. (J Turk Ger Gynecol Assoc 2021; 22: 242-8)
🔖
Cite This Article
TAŞKIN, S., ALTIN, D., ORTAÇ, F. (2022). A short review of current implementations of sentinel lymph node mapping in gynecologic cancers. Journal of the Turkish-German Gynecological Association, Cilt: 22 - Sayı: 3, 93–97. https://ajindex.com/articles/567371
National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology: uterine neoplasms, Version 1.2021. (Accessed on 7.11.2020) https://www.nccn.org/professionals/ physician_gls/pdf/uterine_blocks.pdf 2. National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology: cervical cancer, Version 1.2021. (Accessed on 7.11.2020) https://www.nccn.org/professionals/physician_gls/ pdf/cervical_blocks.pdf 3. National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology: vulvar cancer (squamous cell carcinoma), Version 2.2021. Accessed on 7.11.2020 https://www.nccn.org/ professionals/physician_gls/pdf/vulvar_blocks.pdf 4. Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and metaanalysis. Am J Obstet Gynecol 2017
e10. 5. Rob L, Robova H, Halaska MJ, Hruda M, Skapa P. Current status of sentinel lymph node mapping in the management of cervical cancer. Expert Rev Anticancer Ther 2013
Meads C, Sutton AJ, Rosenthal AN, Malysiak S, Kowalska M, Zapalska A, et al. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer 2014
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet 2016
Carlson JW, Kauderer J, Hutson A, Carter J, Armer J, Lockwood S, et al. GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients. Gynecol Oncol 2020
Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008
ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009
Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz GC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000
Altin D, Taşkın S, Kahramanoglu I, Vatansever D, Tokgozoglu N, Karabük E, et al. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).